Report Detail

1 Introduction 8

  • 1.1 Industry Definition and Research Scope 8
    • 1.1.1 Industry Definition 8
    • 1.1.2 Research Scope 9
  • 1.2 Research Methodology 12
    • 1.2.1 Overview of Market Research Methodology 12
    • 1.2.2 Market Assumption 13
    • 1.2.3 Secondary Data 13
    • 1.2.4 Primary Data 13
    • 1.2.5 Data Filtration and Model Design 14
    • 1.2.6 Market Size/Share Estimation 15
    • 1.2.7 Research Limitations 16
  • 1.3 Executive Summary 17

2 Market Overview and Dynamics 19

  • 2.1 Market Size and Forecast 19
    • 2.1.1 Impact of COVID-19 on World Economy 20
    • 2.1.2 Impact of COVID-19 on the Market 22
  • 2.2 Major Growth Drivers 24
  • 2.3 Market Restraints and Challenges 27
  • 2.4 Emerging Opportunities and Market Trends 30
  • 2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of Global Market by Type 38

  • 3.1 Market Overview by Type 38
  • 3.2 Monoclonal Antibodies 40
  • 3.3 Polyclonal Antibodies 41
  • 3.4 Other Types 42

4 Segmentation of Global Market by Application 43

  • 4.1 Market Overview by Application 43
  • 4.2 Oncology Diagnosis 45
  • 4.3 Hepatitis Diagnosis 46
  • 4.4 Infectious Disease Diagnosis 47
  • 4.5 Dengue Diagnostics 48
  • 4.6 Tuberculosis Diagnostics 49
  • 4.7 HIV Diagnostics 50
  • 4.8 Other Applications 51

5 Segmentation of Global Market by End User 52

  • 5.1 Market Overview by End User 52
  • 5.2 Hospitals & Clinics 54
  • 5.3 Diagnostic Laboratories 55
  • 5.4 Other End Users 56

6 Segmentation of Global Market by Region 57

  • 6.1 Geographic Market Overview 2020-2027 57
  • 6.2 North America Market 2020-2027 by Country 61
    • 6.2.1 Overview of North America Market 61
    • 6.2.2 U.S. 64
    • 6.2.3 Canada 67
    • 6.2.4 Mexico 69
  • 6.3 European Market 2020-2027 by Country 71
    • 6.3.1 Overview of European Market 71
    • 6.3.2 UK 74
    • 6.3.3 France 76
    • 6.3.4 Germany 78
    • 6.3.5 Spain 80
    • 6.3.6 Italy 82
    • 6.3.7 Russia 84
    • 6.3.8 Rest of European Market 86
  • 6.4 Asia-Pacific Market 2020-2027 by Country 88
    • 6.4.1 Overview of Asia-Pacific Market 88
    • 6.4.2 China 91
    • 6.4.3 Japan 93
    • 6.4.4 India 96
    • 6.4.5 Australia 98
    • 6.4.6 South Korea 100
    • 6.4.7 Rest of APAC Region 102
  • 6.5 South America Market 2020-2027 by Country 104
    • 6.5.1 Argentina 107
    • 6.5.2 Brazil 109
    • 6.5.3 Chile 111
    • 6.5.4 Rest of South America Market 113
  • 6.6 MEA Market 2020-2027 by Country 114
    • 6.6.1 UAE 117
    • 6.6.2 Saudi Arabia 119
    • 6.6.3 South Africa 121
    • 6.6.4 Other National Markets 123

7 Competitive Landscape 124

  • 7.1 Overview of Key Vendors 124
  • 7.2 New Product Launch, Partnership, Investment, and M&A 127
  • 7.3 Company Profiles 128

Abbott Laboratories 128

    Abcam plc 130

      Agilent Technologies, Inc. 131

        Aytu BioScience, Inc. 132

          Becton, Dickinson and Company 133

            Bio-Rad Laboratories, Inc. 134

              Boehringer Ingelheim International GmbH 135

                Creative Diagnostics 136

                  Enzo Life Sciences, Inc. 137

                    F. Hoffmann-La Roche AG 138

                      Merck KGaA 139

                        Polymun Scientific Immunbiologische Forschung GmbH 140

                          Sanofi S.A. 141

                            Sartorius AG 142

                              Thermo Fisher Scientific Inc. 143

                                RELATED REPORTS 144

                                Global diagnostic specialty antibodies market will reach $28.97 billion by 2027, growing by 4.9% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer.
                                Highlighted with 79 tables and 70 figures, this 144-page report “Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
                                In-depth qualitative analyses include identification and investigation of the following aspects:
                                • Market Structure
                                • Growth Drivers
                                • Restraints and Challenges
                                • Emerging Product Trends & Market Opportunities
                                • Porter’s Fiver Forces
                                The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Region.

                                Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
                                • Monoclonal Antibodies
                                • Polyclonal Antibodies
                                • Other Types

                                Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
                                • Natural/Biological Products
                                • Synthetic Products

                                Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
                                • Oncology Diagnosis
                                • Hepatitis Diagnosis
                                • Infectious Disease Diagnosis
                                • Dengue Diagnostics
                                • Tuberculosis Diagnostics
                                • HIV Diagnostics
                                • Other Applications

                                Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
                                • Hospitals & Clinics
                                • Diagnostic Laboratories
                                • Other End Users

                                Geographically, the following regions together with the listed national/local markets are fully investigated:
                                • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
                                • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
                                • North America (U.S., Canada, and Mexico)
                                • South America (Brazil, Chile, Argentina, Rest of South America)
                                • MEA (UAE, Saudi Arabia, South Africa)
                                For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Application, and End User over the forecast years are also included.

                                The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
                                Key Players (this may not be a complete list and extra companies can be added upon request):
                                Abbott Laboratories
                                Abcam plc
                                Agilent Technologies, Inc.
                                Aytu BioScience, Inc.
                                Becton, Dickinson and Company
                                Bio-Rad Laboratories, Inc.
                                Boehringer Ingelheim International GmbH
                                Creative Diagnostics
                                Enzo Life Sciences, Inc.
                                F. Hoffmann-La Roche AG
                                Merck KGaA
                                Polymun Scientific Immunbiologische Forschung GmbH
                                Sanofi S.A.
                                Sartorius AG
                                Thermo Fisher Scientific Inc.
                                (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


                                Summary:
                                Get latest Market Research Reports on Diagnostic Specialty Antibodies. Industry analysis & Market Report on Diagnostic Specialty Antibodies is a syndicated market report, published as Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity. It is complete Research Study and Industry Analysis of Diagnostic Specialty Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                Last updated on

                                REPORT YOU MIGHT BE INTERESTED

                                Purchase this Report

                                $3,400.00
                                $5,000.00
                                $6,600.00
                                2,441.20
                                3,590.00
                                4,738.80
                                2,859.40
                                4,205.00
                                5,550.60
                                372,844.00
                                548,300.00
                                723,756.00
                                252,756.00
                                371,700.00
                                490,644.00
                                Credit card Logo

                                Related Reports


                                Reason to Buy

                                Request for Sample of this report